AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with ⁹⁰Y‐loaded glass microsphere radioembolization

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis